Interferon-α treatment of patients with hepatitis C: The role of a comprehensive risk-benefit assessment (multiple letters)

Muhamad Aly Rifai, Jennifer M. Loftis, Peter Hauser, Charles L Raison, Marina Demetrashvili, Lucile Capuron, Andrew H. Miller

Research output: Contribution to journalArticle

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)719-722
Number of pages4
JournalCNS Drugs
Issue number8
Publication statusPublished - 2005
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Neuropsychology and Physiological Psychology
  • Pharmacology

Cite this